Anticancer agent 269
Product Specifications
Target
Apoptosis, Reactive Oxygen Species, Caspase, ROS
Related Pathways
Immunology/Inflammation, Proteases/Proteasome, NF-κB, Metabolism, Apoptosis
Bioactivity
Anticanceragent 269 (Compound 11c) is an orally active caspase-3 activator that exhibits significant anticancer activity by inducing apoptosis through the activation of caspase-3 and promoting ROS generation. It is a valuable compound for research within the cancer field.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K4086602 1.0 µg DNA
Acot10 sgRNA CRISPR Lentivector (Mouse) (Target 1)
Sign In for Pricing
View Details 
RC-16438-01 50 μL
Recombinant Glutamate Receptor 2/Glutamate Receptor 3 Antibody
Sign In for Pricing
View Details RC-16438-02 100 µL
Recombinant Glutamate Receptor 2/Glutamate Receptor 3 Antibody
Sign In for Pricing
View Details RC-16438-03 1 mL
Recombinant Glutamate Receptor 2/Glutamate Receptor 3 Antibody
Sign In for Pricing
View Details 
